Market Analysis of Veterinary Drug Raw Materials
Broad-spectrum antibiotics penicillins:
Penicillin industrial salt--mainstream factories' quotations are strong, trade channels are actively building positions, price performance is strong, market inquiry and procurement consumption is normal (transaction 125-140 yuan / billion), and the current market price index is running strong.
Amoxicillin--mainstream factory quotations are driven by high levels, the market response is high, trade channels are reluctant to sell, the market is highly concerned, and the transaction price follows (transaction 250-260 yuan/kg). The current market price index is running strongly.
Amide alcohols:
Florfenicol--The recent heavy volume of market transactions, willingness to open warehouses in trade channels, the release of cost support news from mainstream factories, delayed delivery, high market attention, intensified efforts to inquire about the spot, and market transaction prices rose (transaction 445-465 Yuan/kg), the current market price index is running strongly.
Tetracyclines:
Oxytetracycline and Oxytetracycline Hydrochloride--The quotations of mainstream factories are stable, the market transactions are average, and the market price index is stable in this period (Oxytetracycline traded at 83-87 yuan/kg, Oxytetracycline hydrochloride traded at 103-110 yuan/kg).
Doxycycline Hydrochloride (Doxycycline) - Recently, the price of mainstream factories has continued to decline (the transaction is 420-435 yuan/kg).
Macrolides:
Erythromycin thiocyanate--mainstream factories have high quotations, limited supply, market prices follow up, and domestic and foreign markets are highly concerned (transactions are at 385-400 yuan/kg). The current market price index is running at a high level and continues to pay attention.
Tylosin, tilmicosin, and tiwanmectin--mainstream factories have insufficient supply, strong willingness to open warehouses in trade channels, active inquiries, and rapid rise in transaction prices (the transaction price is around 260 yuan/kg for wine and taiwan, 325 yuan/kg for phosphine). kg, around 340 yuan/kg of tilmicosin, around 565 yuan/kg of tivallosin, and around 215 yuan/kg of tiamulin), the current market price index is running strongly.
Aminoglycosides:
Streptomycin Sulfate--The market supply is relatively concentrated, the quotations from mainstream factories are high, and the market price index remains stable (transactions are at 260-285 yuan/billion).
Apramycin Sulfate--The quotations of mainstream factories are stable, the market transactions are not significantly heavy, and the price changes are small (transactions are at 200-215 yuan/kg), and the market price index remains stable in this issue.
Neomycin Sulfate--Mainstream factories are willing to raise prices, the market is highly concerned, and transactions are not prosperous. The market price index fluctuated and remained stable in this issue (transactions were at 145-155 yuan/billion).
Gentamicin sulfate--mainstream factories for veterinary products are concentrated in supply, and the market supply price is high (veterinary products traded at 1510-1530 yuan/billion), the transaction is not good, and the market price index performance is slightly weaker, pay attention to the release of news from mainstream manufacturers .
Sulfonamides:
The upstream supply of sulfonamides is relatively concentrated, the price of main upstream raw materials is high, and the market price index fluctuates at a high level. Pay attention. (Sulfachloropyrazine sodium is around 350 yuan/kg, sulfachloropyridazine sodium is around 325 yuan/kg, and sulfamethoxine sodium is around 315 yuan/kg)
Quinolones:
Enrofloxacin and ciprofloxacin--mainstream factories are concentrated in supply, the price of upstream raw materials is high, the price of the factory is firm and then rises, and the limited number of signings is limited, and the market transaction price rises (enuo and ciprofloxacin traded at 255-265 yuan/kg ), the market price index is running strongly.
Antipyretic and analgesic:
Analgin--Mainstream factories are limited in operation, the supply of goods in circulation is relatively concentrated, and the market price index is running at a high level (transactions are at 90-95 yuan/kg).
Paracetamol - Affected by upstream raw materials and other factors, domestic mainstream factories have firm quotations and concentrated supply (transactions are at 65-68 yuan/kg), and the market price index is running at a high level.
Carbaspirin calcium - the supply of mainstream factories is generally, the factory production capacity is relatively scattered, the market transaction price changes slightly (the transaction is about 45 yuan/kg), and the market price index remains stable.
Acetaminophen (Sygnett):
The production recovery of mainstream factories is slow, the supply of upstream raw materials is blocked, the production of various brand factories is not good, limited orders are signed, the market transaction price is high (transaction 76-82 yuan/kg), the market consumption is reduced at high prices, and the current market price index is high run.
Looking for chemical products? Let suppliers reach out to you!
2026-06-12
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Limin builds a joint laboratory with Sichuan Industrial Institute of Antibiotics
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
The Veterinary Drug Industry is Facing a Period of Opportunity for Change, and Leading Animal Health Companies are Expected to Grow Rapidly
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(2)
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
-
Market Analysis of Veterinary Drug Raw Materials
-
Market Analysis of Veterinary Drug Raw Materials
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Week 21 Partial Veterinary Drug Quotes 2
-
Analysis of The Veterinary Drug Raw Material Market in the 21st Week
Recommend Reading
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
Abbott to Market MSD’s Sitagliptin Brands in India Targeting 20 Percent of Diabetes Market
-
Costs Rise, DOP Prices Fluctuate Higher This Week
-
Lipoid Kosmetik Announces New U.S. Market Distribution Partnership with Omya
-
Coking Coal Market Prices Remain Stable
-
Crude oil prices fall, domestic refined oil retail prices are about to be reduced
-
Cyclohexane Market Faces Insufficient Demand, Prices Remain Stable